| Day 1 (12th April 2007) |
08:30-08:45
|
Welcoming Address |
| |
|
| Keynote Lectures
|
| 08:45-09:30 |
Harald zur Hausen (Heidelberg)
"Infections and cancer: novel modes of cancer prevention"
|
| 09:30-10:15 |
Fritz Melchers (Berlin)
"Bone marrow transplantation revised"
|
| 10:15-10:45 |
Coffee Break |
| |
|
Session 1: Defenses against Infectious Pathogens
|
| 10:45-11:25 |
Tom Aebischer (Edinburgh)
"Helicobacter pylori: An update on vaccine development and correlates of immunity"
|
| 11:25-12:05 |
Antonio Coutinho (Oeiras)
To be announced
|
| 12:05-12:45 |
Gillis R. Otten (Emeryville)
To be announced
|
| 13:00-14:15 |
Lunch Break |
| |
|
Poster Session I
|
14:15-15:45
|
Guided Poster Session & Coffee
|
| |
|
Session 2: Biotech boosts Tumorimmunology
Chairperson:
|
16:00-16:30
|
Özlem Türeci (Ganymed, Mainz)
"Novel antibody therapeutics for solid cancers"
|
16:30-17:00
|
Marlies Sproll (Morphosys, Martinsried)
"Human monoclonal antibodies for therapy"
|
17:00-17:30
|
Mark Krul (Isa Pharmaceuticals, Leiden)
"The benefits of biomedical venturing"
|
|
Scientific Program Meeting 2007
Day 2 (13th April 2007) |
Session 3: Tumor Vaccines
|
08:30-09:10
|
Hans-Georg Rammensee (Tübingen)
"Tumor-associated peptides for individualized vaccination"
|
09:10-09:50
|
Christian Ottensmeier (Southampton)
"DNA fusion vaccines against prostate cancer: from the bench to the bedside"
|
09:50-10:30
|
Pramod Srivastava (Farmington)
"gp96-peptide complexes for immunotherapy of stage IV melanoma and adjuvant renal cell carcinoma"
|
10:30-11:00
|
Coffee Break
|
11:00-11:40
|
Yvonne Paterson (Philadelphia)
"Listeria based vaccines for breast and cervical cancer"
|
| |
|
Session 4: Effector Mechanisms in Antibody Based Cancer Therapy
|
| 11:40-12:20
|
Jeffrey V. Ravetch (New York)
"Antibodies and their receptors: linking innate and adaptive immunity"
|
12:20-13:00
|
George Weiner (Iowa City)
"Complement and cellular cytotoxicity in antibody therapy of cancer"
|
| 13:00-14:00 |
Lunch Break |
| |
|
Poster Session II
|
14:00-15:30
|
Guided Poster Session & Coffee
|
| |
|
Session 4 (cont.): Effector Mechanisms in Antibody Based Cancer Therapy
|
15:30-16:10
|
Dario Neri (Zurich)
"Antibody-based vascular tumor targeting: from the bench to the clinic"
|
16:10-16:50
|
Manuel L. Penichet (Los Angeles)
"Antibody-cytokine fusion proteins: applications in cancer therapy"
|
| |
|
Session 5: Development of Immunity
|
| 16:50-17:30
|
Harald von Boehmer (Boston)
"Foxp3 positive Treg: generation, lifestyle and function"
|
20:00
|
Dinner at ”Fürstensaal Residenz Würzburg”
|
|
Scientific Program Meeting 2007
Day 3 (14th April 2007) |
Session 5 (cont.): Development of Immunity
|
08:30-09:10
|
Bruno Kyewski (Heidelberg)
"How promiscuity promotes tolerance"
|
09:10-09:50
|
Sjoerd H. van der Burg (Leiden)
"Tumor-specific T-regulatory cells in tumor-specific vaccination
strategies"
|
09:50-10:30
|
Thomas Boehm (Freiburg)
"Quality strategies in self/non-self discrimination"
|
10:30-11:00
|
Coffee Break
|
| |
|
Session 6: Host-pathogen Interactions
|
11:00-11:40
|
Jörg Hacker (Würzburg)
"Host - microbe interactions in the gastrointestinal tract:
Escherichia coli as an example"
|
11:40-12:30
|
Vincenzo Bronte (Padua)
"Myeloid-derived suppressor cells in cancer:
a novel target for therapeutic invention"
|
12:30-13:10
|
Emmanuel Lemichez (Nice)
"Uropathogenic E. coli CNF1 toxin molecular mechanism of action and application in vaccinology"
|
13:10-13:50
|
Dirk Bumann (Hannover)
"System-level analysis of Salmonella-host interactions"
|
13:50-14:30
|
Lunch Break
|
| |
|
Satellite Session "CIMT Monitoring Panel"
|
| 14:30-15:00 |
Andreas Thiel (Berlin)
"Direct access to CD4 T cells specific for defined antigens according to CD154 expression"
|
| 15:00-15:30
|
Helmut M. Diepolder (Munich)
"HLA class II tetramers for enumeration and phenotyping of hepatitis C virus specific CD4+ T cells"
|
| 15:30-16:00
|
Cedrik M. Britten (Leiden)
"Lessons learned from interlaboratory testing in phases I/2005 and II/2006"
|
| 16:00-16:15
|
Announcement of new panel activities and inter-laboratory testing projects
|
| 16:15-16:45
|
Round table discussion
|
| |
|
